MPOS — Micropos Medical AB (publ) Income Statement
0.000.00%
Last trade - 00:00
- SEK302.33m
- SEK279.78m
- SEK1.64m
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | Interim Report | ARS | ARS | ARS |
Standards: | SAS | — | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.804 | 3.7 | 3.27 | 1.09 | 1.64 |
Cost of Revenue | |||||
Gross Profit | 3.06 | 4.61 | 2.06 | 0.905 | 1.42 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12.6 | 15.9 | 17.7 | 19.6 | 25.5 |
Operating Profit | -11.8 | -12.2 | -14.4 | -18.5 | -23.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -11.8 | -12.3 | -14.4 | -18.6 | -23.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11.8 | -12.3 | -14.4 | -18.6 | -23.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -11.8 | -12.3 | -14.4 | -18.6 | -23.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -11.8 | -12.3 | -14.4 | -18.6 | -23.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.132 | -0.108 | -0.115 | -0.149 | -0.169 |
Dividends per Share |